Oncology Associates of Oregon

Springfield, Oregon 97477

1 studies enrolling now · 2 studies all time

What they study most

HR+ HER2- Breast Cancer, Lymphocytic Leukemia, Chronic

Studies at this site

• Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer — Recruiting now
• A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia — Completed